MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons

Neuroscience

Volumn 169, Issue 1, 2010, Pages 269-278

  Gouty, S ^a   Brown, J M ^a   Rosenberger, J ^a   Cox, B M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Dopamine; GABA; Nociceptin; Orphanin FQ; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MESSENGER RNA; NEUROPEPTIDE; PREPRONOCICEPTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MALE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MPTP POISONING; NEURONS; OPIOID PEPTIDES; PARKINSONIAN DISORDERS; PROTEIN PRECURSORS; RECEPTORS, OPIOID; RNA, MESSENGER; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 77953809653     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.04.033     Document Type: Article

References (36)

1. Ahmad S.O., Park J.-H., Stenho-Bittel L., Lau Y.-S. Effects of endurance exercise on ventral tegmental area neurons in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and probenecid-treated mice. Neurosci Lett 2009, 450:102-105.
2. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990, 13:266-271.
3. Alvarez L., Macias R., Lopez G., Alvarez E., Pavon N., Rodriguez-Oroz M.C., Juncos J.L., Maragoto C., Guridi J., Litvan I., Tolosa E.S., Koller W., Vitek J., DeLong M.R., Obeso J.A. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain 2005, 128:570-583.
4. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990, 249:1436-1438.
5. Blandini F., Nappi G., Tassorelli C., Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 2000, 62:63-88.
6. Bolam J.P., Hanley J.J., Booth P.A.J., Bevan M.D. Synaptic organization of the basal ganglia. J Anat 2000, 196:527-542.
7. Brown J.M., Gouty S., Iyer V., Rosenberger J., Cox B.M. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. J Neurochem 2006, 98:495-505.
8. Buzas B., Rosenberger J., Cox B.M. Activity and cAMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J Neurochem 1998, 71:556-563.
9. Buzas B., Rosenberger J., Kim K.-W., Cox B.M. Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture. Glia 2002, 39:237-246.
10. Cox B.M., Borsodi A., Caló G., et al. Opioid receptors IUPHAR database (IUPHAR-DB) Accessed March 7, 2010. http://www.iuphar-db.org/DATABASE/FamilyMenuForward?familyId=50.
11. Di Benedetto M., Cavina C., D'Addario C., Leoni G., Candeletti S., Cox B.M., Romualdi P. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats. Neuropharmacology 2009, 56:761-767.
12. German D.C., Nelson E.L., Liang C.L., Speciale S.G., Sinton C.M., Sonsalla P.K. The neurotoxoin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration 1996, 5:299-312.
13. Hajós M., Greenfield S.A. Synaptic connections between pars compacta and pars reticulata neurons: electrophysiological evidence for functional modules within the substantia nigra. Brain Res 1994, 660:216-224.
14. Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995, 4:257-269.
15. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci U S A 1999, 96:10444-10449.
16. Lambert D.G. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 2008, 7:694-710.
17. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., Leslie F.M. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. Neuroreport 2002, 13:1137-1140.
18. Mailly P., Charpier S., Menetrey A., Deniau J.-M. Three-dimensional organization of the recurrent axon collateral network of the substantia nigra pars reticulata neurons in the rat. J Neurosci 2003, 23:5247-5257.
19. Mailly P., Charpier S., Menetrey A., Thierry A.M., Glowinski J., Deniau J.-M. Dendritic arborizations of the rat substantia nigra pars reticulata neurons: spatial organization and relation to the lamella compartmentation of striato-nigral projections. J Neurosci 2001, 21:6874-6888.
20. Marti M., Guerrini R., Beani L., Bianchi C., Morari M. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat. Neuroscience 2002, 112:153-160.
21. Marti M., Mela F., Veronesi C., Guerrini R., Salvadori S., Federici M., Mercuri N.B., Rizzi A., Franchi G., Beani L., Bianchi C., Morari M. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. J Neurosci 2004, 24:6659-6666.
22. Marti M., Mela F., Guerrini R., Caló G., Bianchi C., Morari M. Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release. J Neurochem 2004, 91:1501-1504.
23. Marti M., Mela F., Fantin M., Zucchini S., Brown J.M., Witta J., Di Benedetto M., Buzas B., Reinscheid R.K., Salvadori S., Guerrini R., Romualdi P., Candeletti S., Simonato M., Cox B.M., Morari M. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci 2005, 25:9591-9601.
24. Marti M., Trapella C., Morari M. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental Parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA. J Neurochem 2008, 107:1683-1696.
25. Marti M., Trapella C., Viaro R., Morari M. The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway. J Neurosci 2007, 27:1297-1307.
26. Marti M., Viaro R., Guerrini R., Franchi G., Morari M. Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulata. Neuropsychopharmacology 2009, 34:341-355.
27. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 1997, 340:1-15.
28. Nafia I., Re D.B., Masmejean F., Melon C., Kachidian P., Kerkerian-LeGoff L., Nieoullon A., Had-Aissouni H. Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction. J Neurochem 2008, 105:484-496.
29. Neal C.R., Mansour A., Reinscheid R., Nothacker H.-P., Civelli O., Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 1999, 406:503-547.
30. New D.C., Wong Y.H. The ORL1 receptor: molecular pharmacology and signaling mechanisms. Neurosignals 2002, 11:197-212.
31. Norton C.S., Neal C.R., Kumar S., Akil H., Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J Comp Neurol 2002, 444:358-368.
32. Nothacker H.-P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci U S A 1996, 93:8677-8682.
33. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd ed.
34. Rosenberger J., Petrovics G., Buzas B. Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NK-κB. J Neurochem 2001, 79:35-44.
35. Viaro R., Sanchez-Pernaute R., Marti M., Trapella C., Isacson O., Morari M. Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism. Neurobiol Dis 2008, 30:430-438.
36. Witta J., Buzas B., Cox B.M. Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex. J Neurotrauma 2003, 20:523-532.